Is Coya Therapeutics Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Coya Therapeutics Inc (COYA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Coya Therapeutics Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Coya Therapeutics Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Coya Therapeutics Inc?

Muslim investors may consider investing in Coya Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Coya Therapeutics Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Coya Therapeutics Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Coya Therapeutics Inc updated?

The Shariah compliance status of Coya Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Coya Therapeutics Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Coya Therapeutics Inc?

You can check the latest Shariah compliance status of Coya Therapeutics Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

COYA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 17, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Coya Therapeutics Inc (COYA)

Based on 13 analysts giving stock ratings to Coya Therapeutics Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Coya Therapeutics Inc. Stock Analysis COYA

United States Health Care Micro Cap Report: 2025 Annual

The company is headquartered in Houston, Texas and currently employs 8 full-time employees. The company went IPO on 2022-12-29.

Key Statistics of Coya Therapeutics Inc (COYA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$4.90$5.34

Today's Open

$5.34

Volume

152.06K

P/E Ratio (TTM)

52 Week Range

$3.71$7.75

Market Cap

99.69M

Avg. Volume

173.42K

Dividend Yield

Financial Metrics & Statements of Coya Therapeutics Inc (COYA)

FAQ's for Coya Therapeutics Inc (COYA)

According to Musaffa’s Shariah screening methodology, Coya Therapeutics Inc (COYA) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.